Benzinga’s Top Pre-Market Gainers (HDIX, APKT, DDSS, DRAM, NETL, AUXL)

Home Diagnostics, Inc. (NASDAQ: HDIX) climbed 88.93% to $11.43 in the pre-market session. Home Diagnostics announced today that it has signed a definitive merger agreement with Nipro Corporation. In the previous trading session, HDIX closed at $6.05. HDIX has declined over 13% in the last year.

Acme Packet, Inc. (NASDAQ: APKT) jumped 17.99% to $12.59 in the pre-market session. Acme Packet reported yesterday that it expects total revenues to be in the range of $182 million - $186 million, up from prior outlook of $166 million - $168 million and expects non-GAAP diluted earnings per share to be in the range of $0.44 - $0.47, up from prior outlook of $0.41 - $0.42. The 52-week trading range for APKT is $3.96 - $12.25. Acme Packet closed at $10.67 in the last trading session.

Labopharm Inc. (NASDAQ: DDSS) moved up 19.54% to $3.12 after Labopharm announced today that the U.S. Food and Drug Administration has approved OLEPTRO(TM) used for the treatment of major depressive disorder in adults. The 52-week trading range for DDSS is $0.76 - $2.95. Labopharm closed at $2.61 in the previous trading session. DDSS has gained over 31% in the last six months.

Dataram Corporation (NASDAQ: DRAM) surged 11.42% to $3.22 in the pre-market session. In the last trading session, Dataram Corporation closed at $2.89. The 52-week trading range for Dataram Corporation is $1.11 - $5.49. DRAM has surged over 99% in the last six months.

NetLogic Microsystems, Inc. (NASDAQ: NETL) climbed 10.82% to $48.02 in the pre-market session after NetLogic Microsystems announced yesterday a fourth quarter revenue of $69.5 million, as compared to $30.9 million in the year ago period. NetLogic Microsystems closed at $43.33 in the last trading session. In the last year, NETL has gained over 104%.

Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) increased 8.62% to $30.50 after Auxilium Pharmaceuticals announced yesterday that it has received marketing approval from the U.S. Food and Drug Administration for XIAFLEX, used for the treatment of adult Dupuytren's contracture patients with a palpable cord. The 52-week trading range for AUXL is $21.85 - $37.28. In the previous trading session, Auxilium Pharmaceuticals closed at $28.08.


There are 0 comments
Please note that comments may take up to one hour before they get published on the site. Please check back later to see your comments.

Post new comment

The content of this field is kept private and will not be shown publicly.